Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are anticipating strong performance driven by the continued https://aliciavyrm737971.blogrenanda.com/44080111/eli-lilly-s-q3-performance-an-in-depth-look